United States: FDA Finalizes Guidance On DHTs For Remote Data Acquisition - Exponent

Monday, 25 March 2024
New guidance provides recommendations to ensure digital health technologies are fit-for-purpose for collecting high-quality clinical data to evaluate medical products.

👓 View full article

0 shares	Share Tweet Save Post Send

Related videos from verified sources

Nvidia & darpa biohybrid

https://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..

Credit: Rumble Duration: 55:45Published on March 29, 2024

United States: FDA Issues Draft Guidance On Using RWE In Medical Device Submissions - Exponent

New draft guidance describes factors for determining when evidence generated from real-world data may be used to support FDA decisions on medical devices .
Mondaq on March 25, 2024

United States: FDA Finalizes Guidance On DHTs For Remote Data Acquisition - Exponent

You Might Like

Related videos from verified sources

Related news from verified sources

United States: FDA Issues Draft Guidance On Using RWE In Medical Device Submissions - Exponent